RENOVARO INC. - COMMON STOCK

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection

12 7 2021 07:00:01 提供 Nasdaq GlobeNewswire

Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity

30 6 2021 07:00:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology

21 6 2021 07:00:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

14 6 2021 14:53:19 提供 Nasdaq GlobeNewswire

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure

14 6 2021 07:00:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy

12 5 2021 16:29:11 提供 Nasdaq GlobeNewswire

Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy

12 5 2021 08:00:01 提供 Nasdaq GlobeNewswire

Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy

24 3 2021 18:00:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference

22 2 2021 17:15:00 提供 Nasdaq GlobeNewswire